Citigroup
BBNX

Citigroup’s Beta Bionics BBNX Stock Holding History

Citigroup’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.2K Buy
2,013
+69
+4% +$1.02K ﹤0.01% 4820
2025
Q4 		$59.2K Buy
1,944
+463
+31% +$12.4K ﹤0.01% 4511
2025
Q3 		$29.4K Sell
1,481
-3,124
-68% -$54.9K ﹤0.01% 4670
2025
Q2 		$67K Sell
4,605
-4,734
-51% -$67K ﹤0.01% 4618
2025
Q1 		$114K Buy
+9,339
New +$174K ﹤0.01% 4522

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citigroup's BBNX Position: Q1 2026 in Review

Citigroup increased its Beta Bionics (BBNX) stake by 3.5% in Q1 2026, buying an estimated $1.02K and bringing the position to 2,013 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4820.

Citigroup first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $114K in Q1 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Citigroup held 2,013 shares of Beta Bionics worth $20.2K as of Q1 2026.
  • Citigroup bought 69 Beta Bionics shares in Q1 2026, an estimated $1.02K.
  • Beta Bionics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4820 holding.
  • Citigroup first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Citigroup's Beta Bionics position peaked at $114K in Q1 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.